Back
Editas Medicine Stock Predictions
The Next Tech Giant in Your Pocket?
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Sell
40
EDIT
Editas Medicine
Last Price:
3.92
Seasonality Move:
2.24%
7 Day Trial
ALL ACCESS PASS
$
7
32,481% Growth? Meet Mode Mobile's "EarnPhone"
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.Editas Medicine Stock Forecast
-
Is Editas Medicine Stock Undervalued?
The current Editas Medicine [EDIT] share price is $3.87. The Score for EDIT is 40, which is 20% below its historic median score of 50, and infers higher risk than normal. - EDIT is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
Will Editas Medicine Stock Go Up Next Year?
Data Unavailable
Editas Medicine Stock Rating
Data Unavailable
Editas Medicine Stock Price History
Stock Information
Stock Info
Exchange:
NASDAQ
Country:
United States
Industry:
Biotechnology
Sector:
Health Care
Type:
stock
Website:
editasmedicine.com
52-Week Data
52-Week High:
11.69
52-Week Low:
3.40
Prediction Charts
Market Cap:
319.18M
Price in USD:
3.87
Volume:
2.64M
Beta:
2.12
Technical Analysis
SMA50:
4.44
SMA100:
4.88
SMA200:
6.62
52-Wk Change:
-51.69%
Stock Predictions
-
Is Editas Medicine stock public?
Yes, Editas Medicine is a publicly traded company. -
What is the Editas Medicine stock quote today?
The Editas Medicine stock price is 3.87 USD today. -
How to buy Editas Medicine stock online?
You can buy Editas Medicine shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
14-Day Historical Data
| Date | Opening | Closing | Minimum | Maximum |
|---|---|---|---|---|
| Aug-29 | 3.72 | 3.71 | 3.79 | 3.68 |
| Aug-30 | 3.75 | 3.75 | 3.78 | 3.65 |
| Sep-3 | 3.73 | 3.49 | 3.77 | 3.47 |
| Sep-4 | 3.47 | 3.50 | 3.56 | 3.40 |
| Sep-5 | 3.50 | 3.49 | 3.55 | 3.42 |
| Sep-6 | 3.49 | 3.60 | 3.62 | 3.40 |
| Sep-9 | 3.64 | 3.51 | 3.64 | 3.48 |
| Sep-10 | 3.54 | 3.77 | 3.79 | 3.45 |
| Sep-11 | 3.73 | 3.78 | 3.79 | 3.63 |
| Sep-12 | 3.79 | 3.74 | 3.84 | 3.64 |
| Sep-13 | 3.78 | 3.95 | 3.97 | 3.78 |
| Sep-16 | 3.96 | 3.83 | 3.96 | 3.76 |
| Sep-17 | 3.91 | 3.86 | 4.02 | 3.81 |
| Sep-18 | 4.01 | 3.87 | 4.12 | 3.86 |
Editas Medicine Earnings
Data Unavailable
Editas Medicine Forecast Revenue Growth
Data Unavailable
- Analysts estimate an earnings decrease this quarter of $0.24 per share, an increase next quarter of $0.10 per share, a decrease this year of $0.68 per share, and an increase next year of $0.17 per share.
* Editas Medicine stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.